info@seagull-health.com
SeagullHealth
语言:
search
new
How to Purchase Revuforj (Revumenib)
503
Article source: Seagull Pharmacy
Oct 23, 2025

Revuforj (revumenib) is a novel menin inhibitor indicated for the treatment of relapsed or refractory acute leukemia harboring KMT2A gene translocations.

How to Purchase Revuforj (Revumenib)

Overseas Purchase

Patients may choose to consult and purchase Revuforj at hospital pharmacies or licensed retail pharmacies in countries or regions where the drug has been launched.

Since drug prices may be affected by factors such as regional differences and exchange rate fluctuations, patients need to make a budget and plan in advance before purchasing.

Purchase via Medical Service Institutions

Patients can consult domestic overseas medical service institutions that cooperate with international pharmacies or pharmaceutical companies.

These institutions usually provide legal import channels and offer professional consultation and guidance.

Precautions for Purchasing Revuforj (Revumenib)

Strictly Follow Doctor's Instructions

The dosage needs to be adjusted based on the patient's body weight and whether a strong CYP3A4 inhibitor is used in combination (e.g., the standard adult dosage is 270mg twice daily; when used with an inhibitor, the dosage should be reduced to 160mg).

Regular monitoring of electrocardiogram (ECG), serum potassium, serum magnesium, and liver function is required to prevent adverse reactions such as QT interval prolongation.

Contraindications and High-Risk Populations

Absolute Contraindications: Pregnant women (may cause fetal malformations), uncontrolled QT interval prolongation (baseline QTcF > 450msec).

Caution Required: Patients with hepatic impairment, a history of thrombosis, or heart disease need doctors to evaluate the risk-benefit ratio before use.

Be Alert to Drug Interactions

Concurrent use with strong CYP3A4 inducers (e.g., rifampicin) should be avoided, as this may reduce the efficacy of Revuforj.

Dosage adjustment is necessary when Revuforj is used in combination with strong CYP3A4 inhibitors (e.g., posaconazole).

Monitoring of Adverse Reactions

Common side effects include bleeding, nausea, muscle pain, and infection.

If symptoms such as fever, dyspnea, or palpitations occur (which may indicate differentiation syndrome or QT prolongation), immediate medical attention is required.

How to Identify Authentic vs. Counterfeit Revuforj (Revumenib)

Packaging and Appearance

The 25mg tablets are pink, oval-shaped, and engraved with "S" and "25".

The 110mg tablets are beige, oval-shaped, and engraved with "S" and "110".

The 160mg tablets are purple, oval-shaped, and engraved with "S" and "160".

Packaging Integrity: Authentic products are packaged in original aluminum bottles containing desiccants. The label should display the batch number, expiration date, and manufacturer information (Syndax Pharmaceuticals).

Instruction Manual and Label

Authentic products are accompanied by an English instruction manual, which details ingredients, indications, contraindications, and adverse reactions. Counterfeit products may have typographical errors or missing content.

Check for the FDA approval number and NDC (National Drug Code) number.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Recommended Articles
What are the Side Effects of Raloxifene (Evista)?
Raloxifene (Evista) is a Selective Estrogen Receptor Modulator (SERM). It is mainly used for the treatment and prevention of osteoporosis in postmenopausal women, as well as reducing the risk of invas...
Precautions for Administration of Raloxifene (Evista)
Raloxifene (Evista) is a selective estrogen receptor modulator (SERM), primarily used for the treatment and prevention of osteoporosis in postmenopausal women, as well as reducing the risk of invasive...
How to Use Raloxifene (Evista)
Raloxifene (Evista) is a selective estrogen receptor modulator (SERM), mainly used for the treatment and prevention of postmenopausal osteoporosis, and to reduce the incidence of invasive breast cance...
Indications for Raloxifene (Evista)
Raloxifene (Evista) is a selective estrogen receptor modulator (SERM) composed of raloxifene hydrochloride. Since its first approval in the United States in 1997, it has become an important medication...
How to Use Revuforj (Revumenib)
Revuforj (revumenib) is a novel menin inhibitor that received approval from the U.S. Food and Drug Administration (FDA) in 2024 for the treatment of relapsed or refractory acute leukemia (in adults an...
Precautions for Revuforj (Revumenib) AdministrationRevumenib
Revuforj (revumenib) is a novel menin inhibitor that was approved in the United States in 2024 for the treatment of relapsed or refractory acute leukemia harboring KMT2A gene translocation (in adults ...
Common Side Effects of Revuforj (Revumenib)
Revuforj (revumenib) is a novel menin inhibitor indicated for the treatment of relapsed or refractory acute leukemia harboring KMT2A gene translocation. Understanding its side effects and medication p...
Indications for Decitabine and Cedazuridine Tablets (INQOVI)
Decitabine and Cedazuridine Tablets (INQOVI) is an innovative oral fixed-dose combination product, composed of decitabine (a nucleoside metabolism inhibitor) and cedazuridine (a cytidine deaminase inh...
Related Articles
Dosage and Administration, Recommended Dosage of Capmatinib (Tabrecta)
Capmatinib (Tabrecta) is a highly selective MET inhibitor, offering a precision treatment option for patients with metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutation...
What Are the Indications for Capmatinib (Tabrecta)?
Capmatinib (Tabrecta) is a targeted therapy medication that plays an important role in the treatment of non-small cell lung cancer associated with specific gene mutations. As a MET kinase inhibitor, i...
What Are the Purchase Channels for Capmatinib (Tabrecta)?
Capmatinib (Tabrecta) is a highly selective MET inhibitor that has demonstrated significant efficacy in patients with metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutat...
Adverse Reactions of Ivosidenib (Tibsovo)
Ivosidenib (Tibsovo) is an isocitrate dehydrogenase 1 (IDH1) inhibitor, primarily indicated for the treatment of patients with acute myeloid leukemia, myelodysplastic syndromes, and cholangiocarcinoma...
What Are the Precautions for Using Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is a targeted therapy medication primarily indicated for the treatment of patients with malignant hematologic diseases harboring specific gene mutations.What Are the Precautions f...
Dosage and Administration, Recommended Dosage of Ivosidenib (Tibsovo)
Ivosidenib (Tibsovo) is a targeted isocitrate dehydrogenase 1 (IDH1) inhibitor that demonstrates significant value in the treatment of malignant tumors with specific gene mutations.Dosage and Administ...
What Are the Indications for Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is an oral isocitrate dehydrogenase-1 (IDH1) inhibitor indicated for patients with various malignant tumors harboring specific IDH1 gene mutations. By inhibiting the activity of m...
What Are the Purchase Channels for Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is an important targeted therapy drug against IDH1 mutations, demonstrating significant efficacy in diseases such as acute myeloid leukemia and cholangiocarcinoma. For patients in...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved